GMP compliance – Page 40

Stability Study Design for High-Risk APIs: Common Oversights

Identifying and Correcting Stability Study Design Errors in High-Risk APIs Stability study design errors can severely impact product quality and regulatory compliance, especially for high-risk Active Pharmaceutical Ingredients (APIs). These…

Photostability Failures in Injectable Products and CCI Considerations

Addressing Failures in Photostability Testing for Injectable Products and CCI Considerations Photostability study failures can significantly impact the acceptability and marketability of injectable pharmaceutical products. These failures, which can lead…

How Poor Matrix Planning Creates Unusable Stability Results

Exploring Problems with Matrix Planning in Stability Studies Stability study design errors can lead to unusable results, impacting regulatory compliance and product lifecycle management. Such issues are often traced back…

How to Write CAPA for Failed Photostability Study Results

Effective Steps to Address Photostability Study Failures Photostability study failures can pose significant challenges in pharmaceutical manufacturing and quality assurance, impacting product approval and patient safety. Understanding how to respond…

Stability Study Design Errors in Zone IVb Market Submissions

Design Flaws in Stability Studies for Zone IVb Markets: Identifying and Correcting Errors Stability study design errors can present significant challenges for pharmaceutical manufacturers aiming to submit compliant products to…

Photostability Failure Due to Incorrect Lux Hour Calculation

Addressing Photostability Study Failures Linked to Miscalculated Lux Hours Photostability study failures represent a significant concern within pharmaceutical quality assurance processes, particularly when miscalculations in lux hours adversely affect stability…

Why Pilot Batch Stability Data May Not Support Commercial Shelf Life

Understanding Why Pilot Batch Stability Data May Fail to Support Commercial Shelf Life In the realm of pharmaceutical manufacturing, the integrity of stability studies is paramount. Often, pilot batches yield…

How to Assess Photolabile Excipients in Stability Programs

Assessing Photolabile Excipients in Stability Programs: A Practical Guide In the dynamic field of pharmaceutical manufacturing, ensuring the stability of formulations is critical. Photolabile excipients pose unique challenges during stability…

Stability Data Gaps Caused by Poor Batch Selection Strategy

Addressing Stability Study Design Errors Due to Inadequate Batch Selection Strategies Stability study design errors can severely impact the validity of pharmaceutical product shelf-life assessments, leading to compliance issues, financial…

Photostability Study Design for Ophthalmic and Topical Products

Designing Effective Photostability Studies for Ophthalmic and Topical Products In the realm of pharmaceutical manufacturing, photostability study failures pose significant risks to product efficacy and compliance with regulatory expectations. These…

How to Build Stability Studies That Survive FDA and MHRA Review

Resolving Common Stability Study Design Errors for Regulatory Compliance Stability studies are critical in pharmaceutical development, ensuring that products maintain their intended safety and efficacy throughout their shelf life. However,…

Photostability Testing Errors in API Development Programs

Addressing Errors in Photostability Testing During API Development Photostability study failures can significantly impact the regulatory approval process and the overall shelf-life management of active pharmaceutical ingredients (APIs). These failures…